Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma
Phase of Trial: Phase I
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Dexamethasone (Primary) ; Doxorubicin liposomal (Primary) ; Etoposide (Primary) ; Ibrutinib (Primary) ; Rituximab (Primary) ; Temozolomide (Primary) ; Cytarabine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 10 Mar 2018 Status changed from suspended to recruiting.
- 02 Mar 2018 Status changed from recruiting to suspended.
- 19 Jan 2018 Status changed from suspended to recruiting.